All In Biotech

Drug Trial Radar · NCT06445023

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ-CSU1)

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 963 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

963

Actual

Start

Jul 11, 2024

Primary completion

Aug 12, 2026

Study completion Jun 2027

Sponsor

Lead sponsor
Celldex TherapeuticsIndustry
Sponsor type
Industry
First posted
Jun 6, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.

Conditions

  • Chronic Spontaneous Urticaria

Interventions

  • barzolvolimabBiological

    Subcutaneous Administration

  • Matching placeboBiological

    Matching placebo Subcutaneous Administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from baseline to Week 12 of UAS7 (Urticaria Activity Score)Time frame: From Day 1 (first dose) to Day 85 (Week 12)

Locations

235 sites in 21 countries. Site status is shown where the registry gives one.

  • Cahaba Dermatology Skin Health Center

    Birmingham, Alabama

  • First OC Dermatology - Fountain Valley

    Fountain Valley, California

  • 310 Clinical Research

    Inglewood, California

  • Dermatology Research Associates

    Los Angeles, California

  • Focus Clinical Research - Los Angeles

    Los Angeles, California

  • Cura Clinical Research

    Oxnard, California

  • Allergy and Asthma Consultants

    Redwood City, California

  • Acclaim Clinical Research

    San Diego, California

  • West Dermatology Research Center

    San Diego, California

  • Therapeutics Clinical Research

    San Diego, California

  • Orso Health, Inc.

    Torrance, California

  • Integrated Research of Inland, Inc.

    Upland, California

  • Western States Clinical Research Inc

    Wheat Ridge, Colorado

  • Encore Medical Research Boynton Beach

    Boynton Beach, Florida

  • Direct Helpers Research Center

    Hialeah, Florida

  • GSI Clinical Research

    Margate, Florida

  • International Dermatology Research Inc - Miami

    Miami, Florida

  • Miami Dade Medical Research Institute, LLC

    Miami, Florida

  • Sarasota Clinical Research

    Sarasota, Florida

  • GCP Global Clinical Professionals, LLC

    St. Petersburg, Florida

  • Paradigm Clinical Research Boise

    Boise, Idaho

  • Endeavor Health

    Skokie, Illinois

  • Dawes Fretzin Clinical Research Group-7910 N Shadeland Ave

    Indianapolis, Indiana

  • DS Research of Kentucky, LLC

    Louisville, Kentucky

  • Allergy and Asthma Specialists PSC

    Owensboro, Kentucky

  • Clinical Trials Management LLC - Southshore Office

    Metairie, Louisiana

  • Johns Hopkins Asthma and Allergy Center

    Baltimore, Maryland

  • DermAssociates, LLC

    Rockville, Maryland

  • Institute For Asthma and Allergy

    Wheaton, Maryland

  • David Fivenson MD Dermatolgy PLLC

    Ann Arbor, Michigan

  • Resp Medicine Research Institute of MI

    Ypsilanti, Michigan

  • Dermatolgy and Skin Cancer Center

    Lee's Summit, Missouri

  • MediSearch, LLC

    Saint Joseph, Missouri

  • Montana Medical Research

    Missoula, Montana

  • Excel Clinical Research - Las Vegas

    Las Vegas, Nevada

  • Allergy Partners of N.J., P.C.

    Ocean City, New Jersey

  • Finger Lakes Medical Research, PLLC

    Cortland, New York

  • Sadick Research Group

    New York, New York

  • Bexley Dermatology Research

    Bexley, Ohio

  • Apex Clinical Research

    Canton, Ohio

Showing 40 of 235 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.